4 Comments
User's avatar
Mary P.'s avatar

Thank you for sharing this very valuable information. This was so appreciated.

Expand full comment
Greg Brozeit's avatar

Excellent advice. Another example of Bart Barlogie's impact on today.

Expand full comment
Andrew Cowan, MD's avatar

Thanks, Greg! Agree - Barlogie’s impact continues on today.

Expand full comment
Vicki Anderson's avatar

I am 69 and in my third year of treatment with Darzalex/Revlimid/Dexamethasone. Have been doing great but myeloma has recently started to do an end run around treatment with my lambda free lightchains increasing. I do have a comorbidity with heart issues. I am very excited that my Dr. is steering me to a bispecific antibodies trial. I was glad to read your chess analogy listing this as one of my better choices. We will get as much as we can from my current treatment before trying the bispecific option. Thank you for your post. Very timely for me.

Expand full comment